The (3-adrenergic receptor kinase is an enzyme, possibly analogous to rhodopsin kinase, that multiply phosphorylates the (3-adrenergic receptor only when it is occupied by stimulatory agonists. Since this kinase may play an important role in mediating the process of homologous, or agonist-specific, desensitization, we investigated the functional consequences of receptor phosphorylation by the kinase and possible analogies with the mechanism of action of rhodopsin kinase. Pure hamster lung 182-adrenergic receptor, reconstituted in phospholipid vesicles, was assessed for its ability to mediate agonist-promoted stimulation of the GTPase activity of coreconstituted stimulatory guanine nucleotide-binding regulatory protein. When the receptor was phosphorylated by partially ("350-fold) purified preparations of ,B-adrenergic receptor kinase, as much as 80% inactivation of its functional activity was observed. However, the use of more highly purified enzyme preparations led to a dramatic decrease in the ability of phosphorylation to inactivate the receptor such that pure enzyme preparations (""20,000-fold purified) caused only minimal (""16 ± 7%) inactivation. Addition of pure retinal arrestin (48-kDa protein or S antigen), which is involved in enhancing the inactivating effect of rhodopsin phosphorylation by rhodopsin kinase, led to partial restoration of the functional effect of ,B-adrenergic receptor kinase-promoted phosphorylation (41 + 3% inactivation). These results suggest the possibility that a protein analogous to retinal arrestin may exist in other tissues and function in concert with ,I-adrenergic receptor kinase to regulate the activity of adenylate cyclase-coupled receptors.
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Transmembrane signaling systems for converting extracellular stimuli as divergent as hormones, drugs, or photons of light into intracellular metabolic changes have been remarkably conserved through evolution. Such systems generally consist of three major components: a receptor, such as the P-adrenergic receptor (J3AR) or the visual "light receptor" rhodopsin; a guanine nucleotide-binding regulatory protein, such as the stimulatory guanine nucleotide-binding regulatory protein (Gs) or transducin; and an effector, such as adenylate cyclase or cGMP phosphodiesterase (1) (2) (3) (4) . Not only are such systems analogous, but individual components are actually homologous proteins such as the ,BAR and rhodopsin or Gs and transducin. Moreover, two analogous enzymes that may function to regulate the activities of such systems have been described. Rhodopsin kinase is a cytosolic enzyme that phosphorylates only the light-bleached form of rhodopsin on multiple serine and threonine residues (up to 9 mol of phosphate per mol of receptor) and is thought to be involved in deactivating the illuminated form of rhodopsin so that it does not continue to activate transducin (5, 6) . P3AR kinase is a ubiquitously distributed cytosolic enzyme that phosphorylates only the agonist-occupied form of the PAR (up to 9 mol of phosphate per mol) (7) . It is probably involved in phosphorylating and regulating other adenylate cyclasecoupled receptors as well (8, 9) . We have proposed that PAR kinase may mediate the phosphorylation of the P3AR that accompanies and may cause the "homologous" or agonistspecific form of adenylate cyclase desensitization.
Phosphorylation of rhodopsin by rhodopsin kinase only partially explains the diminished capacity of phosphorylated rhodopsin to activate transducin. In addition, another cytosolic retinal protein, variably termed 48-kDa protein, S antigen, or arrestin, binds specifically to phosphorylated rhodopsin and, thereby, inhibits its ability to interact with transducin (6) .
In the present studies we have investigated the functional consequences of phosphorylation of purified mammalian f82-adrenergic receptor with ,AR kinase by assessing the ability of these receptors to mediate the agonist-promoted stimulation of the GTPase activity of Gs in a reconstituted system. Moreover, a functionally important interaction of purified retinal arrestin with this system is documented.
METHODS
Protein Purification. ,B-Adrenergic receptor from hamster lung was purified to >95% homogeneity by sequential affinity chromatography and HPLC as described (10) .
Gs was purified from a cholate extract of washed human erythrocyte membranes as described (11) . The preparations used in these experiments were from step 8A in ref. 11 and were >95% pure as judged by Coomassie blue staining of polyacrylamide gels.
,BAR kinase was purified from bovine brain by (NH4)2SO4 precipitation of a high-speed supernatant fraction as described (12 Arrestin was purified to >90% homogeneity from bovine retina using its reversible binding to phosphorylated rhodopsin (13) . Some preparations were further purified to apparent homogeneity by FPLC using a Mono Q column (13) . Both preparations gave identical results.
Phosphorylation. Purified PAR (25-50 pmol) was initially reconstituted in soybean phosphatidylcholine vesicles as described (7, 14 In addition, to inhibit endogenous cAMP-dependent protein kinase present in the crude PAR kinase preparations a peptide inhibitor of this kinase was included in most experiments at a concentration of 5 ,ug/ml. This inhibitor is a synthetic peptide comprising the 24 amino-terminal residues of the specific cAMP-dependent protein kinase inhibitor (15, 16) . In some experiments (see Fig. 1 ), 20 ml of cold 100 mM NaCl/10 mM Tris HCI, pH 7.2/2 mM EDTA was added after the incubation period. The samples were then centrifuged (350,000 X g for 60 min), and the resultant pellets were resuspended in 300 Al of 100 mM NaCl/10 mM Tris HCI, pH 7.2. Samples were incubated with G. before assaying for GTPase activity. In other experiments (see Figs. 2 and 3), following a 1-hr incubation at 300C, the samples were diluted with 250 Al of cold 100 mM NaCl/10 mM Tris-HCI, pH 7.2.
The diluted samples containing either control or phosphorylated FAR were then incubated with Gs and retinal arrestin (see Fig. 3 ) for 20 min on ice. Samples were then assayed for GTPase activity. In these studies, the stoichiometry of phosphorylation varied depending on the particular PAR (17) . Isoproterenol-stimulated GTPase activity was calculated as the difference between the activity in the presence of isoproterenol and in the presence of alprenolol and generally represented an =3-fold stimulation by the agonist.
Electrophoresis. Gel electrophoresis was performed by the method of Laemmli (18) using 10% polyacrylamide gels. Sample buffer consisted of 8% (wt/vol) NaDodSO4, 10O (vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol, 25 mM Tris'HC1 (pH 6.5), and 0.003% bromphenol blue. After electrophoresis, gels were immediately dried prior to autoradiography at -90'C.
RESULTS
Initially, partially purified preparations of PAR kinase were used to phosphorylate the reconstituted purified OAR. These enzyme preparations, which were -1% pure, had been chromatographed on an Ultrogel AcA 34 column after (NH4)2SO4 precipitation and were purified -350-fold from the starting material (12) . As shown in Fig. 1 samples were resuspended in NaDodSO4 sample buffer before electrophoresis on a 1o polyacrylamide gel. Stoichiometries of phosphorylation were determined as described (7, 12) . Pellets from the p[NH]ppA and ATP incubations were resuspended in 300 Al of 100 mM NaCl/10 mM Tris HCl, pH 7.2. Samples (containing -0.4 pmol of 8AR) were then incubated with -1.5 pmol of G0 for 20 min at 40C before assaying for isoproterenol-stimulated GTPase activity. the affinity of several ligands for binding to control and phosphorylated receptors was not altered. The loss of function was also not due to proteolysis since, as assessed by NaDodSO4/PAGE, the molecular weight of the receptor is unaltered (data not shown).
While phosphorylation of the receptor by partially purified (PAR kinase preparations was accompanied by a parallel reduction in receptor activity, this effect was substantially lost as the kinase was further purified. Fig. 2 Fig. 1 were chromatographed on DEAESephacel columns, a further =2-fold purification occurred.
As described (12) , in this step of purification PAR kinase Since it has been demonstrated (6) that inactivation of light-promoted phosphodiesterase activity is enhanced by binding of arrestin to phosphorylated rhodopsin, we tested the effects of purified retinal arrestin in the PAR system. The results are shown in Fig. 3 . In the absence of arrestin, the phosphorylated receptor stimulated G.-associated GTPase activity to 84.4 + 6.8% (n = 5) of that obtained with the unphosphorylated receptor. Addition of increasing amounts of arrestin to the reconstituted j3AR/Gs/pure PAR kinase system has no effect on receptor activity under nonphosphorylating conditions. Thus, the mean activity of control receptor in the presence of various levels of arrestin was 98.1 3.5% (n = 13) of the value in the absence of arrestin.
However, following the phosphorylation of PAR by ATP and pure ,AR kinase, addition of various amounts of arrestin leads to a progressive reduction in receptor-Gs interaction, such that at high arrestin (arrestin/G. molar ratio, >100:1) only 59.3 ± 2.6% (n = 9) of control activity is observed (P < 0.001). This effect was shown to be specific as it required the simultaneous presence of,AR kinase-phosphorylated PAR, Gs, and arrestin. Arrestin could not be replaced by bovine 
DISCUSSION
These results have important implications for understanding the possible mechanisms by which covalent modification of adenylate cyclase-coupled receptors may regulate their function. Phosphorylation of the PAR by partially purified preparations of PAR kinase clearly leads to receptor inactivation, apparent as an impairment ofreceptor coupling to Gs. In clear analogy with the retinal system for inactivating rhodopsin (6), the functional effect ofPAR kinase appears to be significantly enhanced by some other cytosolic factor(s) that is separated from PAR kinase during its purification. The existence of such a factor that may be similar to the retinal protein is suggested, because authentic retinal arrestin can augment the effect of /AR kinase. Possibly, with the nonretinal homolog of this protein, even more dramatic effects on the function of the receptor would be observed. In this connection it can also be noted that the molar ratios of arrestin/G. (>100:1) required for inactivation of phosphorylated PAR are significantly higher than the arrestin/transducin molar ratio (<10:1) required for comparable effects on phosphorylated rhodopsin (6) . Since antibodies to arrestin do not identify cross-reactive proteins in tissues other than the pineal (20) , there may be significant differences in the structure of any such putative arrestin-like protein in nonretinal tissues.
Step AcA34 DEAE CM % Purity 0. Additional studies will be necessary to determine the correlation between phosphorylation stoichometry and desensitization.
The concerted effects of PAR kinase and retinal arrestin on the function of the PAR further extend the growing list of analogies between the visual and hormonal membrane signaling systems. These analogies must now be extended to include the mechanisms of regulation of receptor function at the molecular level.
